Developing a Tretinoin Oral Liquid for Patients Who Cannot Take Capsules
Download in electronic PDF format for $65
Abstract: Published information on alternative ways to administer commercial dosage forms may not always be the best option for patients and the hospital staff. There are resources available to research information about drugs and excipients. A compounding pharmacist can review the information and, based on training and experience in compounding, develop a formulation to meet the individual needs of a patient. The tretinoin oral suspension formulation included with this article is an example of how to develop a formulation without a published stability study by utilizing various compounding references and databases.
Related Keywords:
Linda F. McElhiney, PharmD, RPh, FIACP, FASHP, tretinoin, oral suspension, retinoid, retin A, category X, excipients, all-trans-retinoic acid, formulation
Related Categories:
CANCER AND AIDS, DERMATOLOGY, EXCIPIENTS, FORMULATIONS, STABILITIES, COMPATIBILITIES
Printer-Friendly Version
| Related Articles from IJPC |
Title/Author
(Click for Abstract / Details / Purchase) |
Issue/Page
View/Buy |
Developing a Tretinoin Oral Liquid for Patients Who Cannot Take Capsules
McElhiney Linda F
|
Mar/Apr 2010
Pg. 118-123
|
Acidifying Agents, Featured Excipient:
Allen Loyd V Jr
|
Jul/Aug 1999
Pg. 309-310
|
A Need for Propylene Glycol-Free Ascorbic Acid Oral Liquid
McElhiney Linda F
|
Nov/Dec 2004
Pg. 458-460
|
Nimodipine Compounded Oral Suspension: A True Documented Medical Need
McElhiney Linda F
|
Mar/Apr 2019
Pg. 106-111
|
Case Report: The Quest for a Palatable Compounded Metronidazole (Base) Suspension
McElhiney Linda F
|
Jan/Feb 2021
Pg. 24-28
|
Preventing Medication Errors with Nimodipine by Compounding Proper Dosage Forms
McElhiney Linda F
|
Sep/Oct 2013
Pg. 364-368
|
Stability of Extemporaneously Prepared Hydroxycarbamide Oral Suspensions
Kabiche Djamila, Balde Issa-Bella, Majoul Elyes, Kabiche Sofiane, Bourguignon Elodie, Fontan Jean-Eudes, Cisternino Salvatore, Schlatter Joel
|
Mar/Apr 2017
Pg. 160-163
|
Calculating Carbohydrate Content of Compounded Medications for Patients on a Ketogenic Diet
McElhiney Linda F, Cheng Angela, Meshberger Laura, Imai Lara
|
Jan/Feb 2010
Pg. 21-25
|
Pharmacies on the Frontline: Responding to the COVID-19 Pandemic
McElhiney Linda F
|
Jul/Aug 2020
Pg. 287-295
|
Optimizing Third-party Reimbursement for Compounded Medications
McElhiney Linda F
|
May/Jun 2013
Pg. 201-204
|
